_id
691727703c536f8df2316c06
Ticker
VACBF
Name
Nykode Therapeutics AS
Exchange
PINK
Address
Oslo Research Park, Oslo, Norway, 0349
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://nykode.com
Description
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of locally advanced and metastatic tumors; and VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer. Nykode Therapeutics AS was founded in 2006 and is headquartered in Oslo, Norway.
Last Close
0.1558
Volume
-
Current Price
0.1558
Change
0
Last Updated
2026-01-07T14:01:53.926Z
Image
https://logo.clearbit.com/nykode.com
Ipo Date
-
Market Cap
121666840
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.994
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
6277000
Operating Income
-6277000
Interest Expense
30000
Pretax Income
-4976000
Net Income
-3660000
Eps
-0.011208206572906365
Dividends Per Share
-
Shares Outstanding
326546444
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
63930000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
66932000
Property Plant Equipment
6187000
Total Assets
105698000
Payables
1991000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
6445000
Equity
99253000
Bs_currency_symbol
USD
Depreciation
507000
Change In Working Capital
-1145000
Cash From Operations
-6017000
Capital Expenditures
1000
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-6344000
Cf_currency_symbol
USD
PE
-
PB
0.5125883950631215
ROE
-3.687545968383827
ROA
-3.462695604457984
FCF
-6018000
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
6277000
Quarters > 0 > income Statement > operating Income
-6277000
Quarters > 0 > income Statement > interest Expense
30000
Quarters > 0 > income Statement > pretax Income
-4976000
Quarters > 0 > income Statement > net Income
-3660000
Quarters > 0 > income Statement > eps
-0.011208206572906365
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
326546444
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
63930000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
66932000
Quarters > 0 > balance Sheet > property Plant Equipment
6187000
Quarters > 0 > balance Sheet > total Assets
105698000
Quarters > 0 > balance Sheet > payables
1991000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6445000
Quarters > 0 > balance Sheet > equity
99253000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3660000
Quarters > 0 > cash Flow > depreciation
507000
Quarters > 0 > cash Flow > change In Working Capital
-1145000
Quarters > 0 > cash Flow > cash From Operations
-6017000
Quarters > 0 > cash Flow > capital Expenditures
1000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-6344000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.011208206572906365
Quarters > 0 > ratios > PB
0.5125883950631215
Quarters > 0 > ratios > ROE
-3.687545968383827
Quarters > 0 > ratios > ROA
-3.462695604457984
Quarters > 0 > ratios > FCF
-6018000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
6679000
Quarters > 1 > income Statement > operating Income
-6679000
Quarters > 1 > income Statement > interest Expense
33000
Quarters > 1 > income Statement > pretax Income
-1180000
Quarters > 1 > income Statement > net Income
859000
Quarters > 1 > income Statement > eps
0.0026305599579580785
Quarters > 1 > income Statement > dividends Per Share
32279000
Quarters > 1 > income Statement > shares Outstanding
326546444
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
69986000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
72754000
Quarters > 1 > balance Sheet > property Plant Equipment
6625000
Quarters > 1 > balance Sheet > total Assets
111609000
Quarters > 1 > balance Sheet > payables
2964000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8842000
Quarters > 1 > balance Sheet > equity
102767000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
8689470
Quarters > 1 > cash Flow > depreciation
510000
Quarters > 1 > cash Flow > change In Working Capital
-2072000
Quarters > 1 > cash Flow > cash From Operations
-7902000
Quarters > 1 > cash Flow > capital Expenditures
9000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-39485000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.0026305599579580785
Quarters > 1 > ratios > PB
0.4950610212928274
Quarters > 1 > ratios > ROE
0.8358714373291036
Quarters > 1 > ratios > ROA
0.7696511930041484
Quarters > 1 > ratios > FCF
-7911000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
58
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
7543000
Quarters > 2 > income Statement > operating Income
-7543000
Quarters > 2 > income Statement > interest Expense
33000
Quarters > 2 > income Statement > pretax Income
-3496000
Quarters > 2 > income Statement > net Income
-1444000
Quarters > 2 > income Statement > eps
-0.004422035598709505
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
326546444
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
106234000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
108606000
Quarters > 2 > balance Sheet > property Plant Equipment
7165000
Quarters > 2 > balance Sheet > total Assets
146614000
Quarters > 2 > balance Sheet > payables
3381000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
12667000
Quarters > 2 > balance Sheet > equity
133947000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-14643370
Quarters > 2 > cash Flow > depreciation
518000
Quarters > 2 > cash Flow > change In Working Capital
-3356000
Quarters > 2 > cash Flow > cash From Operations
-10362000
Quarters > 2 > cash Flow > capital Expenditures
30000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-10361000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.004422035598709505
Quarters > 2 > ratios > PB
0.37982139185797364
Quarters > 2 > ratios > ROE
-1.0780383285926523
Quarters > 2 > ratios > ROA
-0.9848991228668477
Quarters > 2 > ratios > FCF
-10392000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
6773000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
12762000
Quarters > 3 > income Statement > operating Income
-5989000
Quarters > 3 > income Statement > interest Expense
42000
Quarters > 3 > income Statement > pretax Income
-6987000
Quarters > 3 > income Statement > net Income
-6756000
Quarters > 3 > income Statement > eps
-0.020689246887036994
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
326546444
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-88.42462719622029
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
114818000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
117066000
Quarters > 3 > balance Sheet > property Plant Equipment
7744000
Quarters > 3 > balance Sheet > total Assets
153481000
Quarters > 3 > balance Sheet > payables
864000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
17267000
Quarters > 3 > balance Sheet > equity
136214000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-75223940
Quarters > 3 > cash Flow > depreciation
547000
Quarters > 3 > cash Flow > change In Working Capital
-4608000
Quarters > 3 > cash Flow > cash From Operations
-11401000
Quarters > 3 > cash Flow > capital Expenditures
49000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-8642000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.020689246887036994
Quarters > 3 > ratios > PB
0.37350005120765856
Quarters > 3 > ratios > ROE
-4.95984260061374
Quarters > 3 > ratios > ROA
-4.401847785719405
Quarters > 3 > ratios > FCF
-11450000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.6905359515724199
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8679000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
57012000
Annuals > 0 > income Statement > operating Income
-48333000
Annuals > 0 > income Statement > interest Expense
188000
Annuals > 0 > income Statement > pretax Income
-45513000
Annuals > 0 > income Statement > net Income
-38821000
Annuals > 0 > income Statement > eps
-0.11888354846087376
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
326546444
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-556.8959557552714
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
114818000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
117066000
Annuals > 0 > balance Sheet > property Plant Equipment
7744000
Annuals > 0 > balance Sheet > total Assets
153481000
Annuals > 0 > balance Sheet > payables
864000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
17267000
Annuals > 0 > balance Sheet > equity
136214000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-38821000
Annuals > 0 > cash Flow > depreciation
2251000
Annuals > 0 > cash Flow > change In Working Capital
-9149000
Annuals > 0 > cash Flow > cash From Operations
-51220000
Annuals > 0 > cash Flow > capital Expenditures
71000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-45689000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.11888354846087376
Annuals > 0 > ratios > PB
0.37350005120765856
Annuals > 0 > ratios > ROE
-28.50000734138928
Annuals > 0 > ratios > ROA
-25.29368456030388
Annuals > 0 > ratios > FCF
-51291000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-5.909782232976149
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
12902000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
70984000
Annuals > 1 > income Statement > operating Income
-58082000
Annuals > 1 > income Statement > interest Expense
224000
Annuals > 1 > income Statement > pretax Income
-44086000
Annuals > 1 > income Statement > net Income
-35154000
Annuals > 1 > income Statement > eps
-0.10765390542730884
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
326546444
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-450.1782669353589
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
161954000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
165675000
Annuals > 1 > balance Sheet > property Plant Equipment
10517000
Annuals > 1 > balance Sheet > total Assets
208185000
Annuals > 1 > balance Sheet > payables
1327000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
36926000
Annuals > 1 > balance Sheet > equity
171259000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-372269260
Annuals > 1 > cash Flow > depreciation
2122000
Annuals > 1 > cash Flow > change In Working Capital
-44882000
Annuals > 1 > cash Flow > cash From Operations
-96624000
Annuals > 1 > cash Flow > capital Expenditures
1902000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-44995000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.10765390542730884
Annuals > 1 > ratios > PB
0.2970701450738355
Annuals > 1 > ratios > ROE
-20.52680443071605
Annuals > 1 > ratios > ROA
-16.885942791267382
Annuals > 1 > ratios > FCF
-98526000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-7.636490466594326
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
7168000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
60721000
Annuals > 2 > income Statement > operating Income
-53553000
Annuals > 2 > income Statement > interest Expense
241000
Annuals > 2 > income Statement > pretax Income
-50983000
Annuals > 2 > income Statement > net Income
-42743000
Annuals > 2 > income Statement > eps
-0.14504182366141316
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
294694309
Annuals > 2 > income Statement > income Tax Expense
-8240000
Annuals > 2 > income Statement > EBITDA
-48928000
Annuals > 2 > income Statement > operating Margin
-747.1121651785714
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
205843000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2544000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
211873000
Annuals > 2 > balance Sheet > property Plant Equipment
9526000
Annuals > 2 > balance Sheet > total Assets
221477000
Annuals > 2 > balance Sheet > payables
2313000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
64458000
Annuals > 2 > balance Sheet > equity
157019000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-441700180
Annuals > 2 > cash Flow > depreciation
1814000
Annuals > 2 > cash Flow > change In Working Capital
25908000
Annuals > 2 > cash Flow > cash From Operations
-20693000
Annuals > 2 > cash Flow > capital Expenditures
2675000
Annuals > 2 > cash Flow > cash From Investing
11050000
Annuals > 2 > cash Flow > cash From Financing
360000
Annuals > 2 > cash Flow > net Change In Cash
-9843000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.14504182366141316
Annuals > 2 > ratios > PB
0.2924064816499914
Annuals > 2 > ratios > ROE
-27.221546437055387
Annuals > 2 > ratios > ROA
-19.29906942933126
Annuals > 2 > ratios > FCF
-23368000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.260044642857143
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
33963000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
44738000
Annuals > 3 > income Statement > operating Income
-10775000
Annuals > 3 > income Statement > interest Expense
130000
Annuals > 3 > income Statement > pretax Income
-11117000
Annuals > 3 > income Statement > net Income
-9414000
Annuals > 3 > income Statement > eps
-0.03250472760960575
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
289619409
Annuals > 3 > income Statement > income Tax Expense
-1704000
Annuals > 3 > income Statement > EBITDA
-10252000
Annuals > 3 > income Statement > operating Margin
-31.72570149868975
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
215759000
Annuals > 3 > balance Sheet > short Term Investments
12169000
Annuals > 3 > balance Sheet > receivables
23750000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
255858000
Annuals > 3 > balance Sheet > property Plant Equipment
9165000
Annuals > 3 > balance Sheet > total Assets
265556000
Annuals > 3 > balance Sheet > payables
2746000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
71501000
Annuals > 3 > balance Sheet > equity
194055000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-82321440
Annuals > 3 > cash Flow > depreciation
734000
Annuals > 3 > cash Flow > change In Working Capital
8011000
Annuals > 3 > cash Flow > cash From Operations
1155000
Annuals > 3 > cash Flow > capital Expenditures
871000
Annuals > 3 > cash Flow > cash From Investing
10753000
Annuals > 3 > cash Flow > cash From Financing
20441000
Annuals > 3 > cash Flow > net Change In Cash
32379000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.03250472760960575
Annuals > 3 > ratios > PB
0.23252533519981447
Annuals > 3 > ratios > ROE
-4.851201978820438
Annuals > 3 > ratios > ROA
-3.545014987422615
Annuals > 3 > ratios > FCF
284000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.008362041044666254
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.011208206572906365
Valuation > metrics > PB
0.5125883950631215
Valuation > final Score
70
Valuation > verdict
48.7% Undervalued
Profitability > metrics > ROE
-3.687545968383827
Profitability > metrics > ROA
-5.468236419052172
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.06493506493506493
Risk > metrics > Interest Coverage
-209.23333333333332
Risk > final Score
-777
Risk > verdict
High
Liquidity > metrics > Current Ratio
33.61727774987443
Liquidity > metrics > Quick Ratio
33.61727774987443
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
20
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-750
Prev Risks > 1
-854
Prev Risks > 2
-510
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:46:18.582Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.25
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-24
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0112
Earnings History > 1 > eps Estimate
-0.25
Earnings History > 1 > eps Difference
0.2388
Earnings History > 1 > surprise Percent
95.52
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-27
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0026
Earnings History > 2 > eps Estimate
-0.23
Earnings History > 2 > eps Difference
0.2326
Earnings History > 2 > surprise Percent
101.1304
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-16
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0044
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0207
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-27
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0298
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-21
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0226
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0458
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0163
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0347
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0312
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0351
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of locally advanced and metastatic tumors; and VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer. Nykode Therapeutics AS was founded in 2006 and is headquartered in Oslo, Norway.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Nykode Therapeutics AS
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.25
Date
2025-09-30
EPS Actual
-0.0112
EPS Estimate
-0.25
EPS Difference
0.2388
Surprise Percent
95.52%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.